Genomic Analysis of Pediatric Bone Tumors
Public ClinicalTrials.gov record NCT01047878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Genomic Analysis of Pediatric Bone Tumors (Other Title: Pediatric Bone Tumor Biology Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Study identification
- NCT ID
- NCT01047878
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Up to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- May 31, 2018
- Completion
- Nov 30, 2019
- Last update posted
- Jul 27, 2020
2007 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Bone Cancer trials
Other public records listing Bone Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT03678883: 9-ING-41 in Patients With Advanced Cancers Active, not recruiting
- NCT03160274: Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions Recruiting
- NCT02880319: Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone Active, not recruiting
- NCT04974008: Osteosarcoma Maintenance Therapy With OST31-164 Active, not recruiting
- NCT06070259: Insights Into Participating in Studies for Bone Cancer Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01047878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2020 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01047878 live on ClinicalTrials.gov.